Cyclophosphamide use in treatment of refractory Kawasaki disease with coronary artery aneurysms
Cyclophosphamide use in treatment of refractory Kawasaki disease with coronary artery aneurysms
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Despite timely administration of IVIG, some patients with Kawasaki disease (KD) develop rapidly progressive or giant coronary artery aneurysms (CAA).
We describe our experience using cyclophosphamide (CYC) for the treatment of such cases as well as a review of the literature on the use of CYC in KD. Through a retrospective chart review of our KD...
Alternative Titles
Full title
Cyclophosphamide use in treatment of refractory Kawasaki disease with coronary artery aneurysms
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_66b8c689e5a449f98b74a25acedbcd6f
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_66b8c689e5a449f98b74a25acedbcd6f
Other Identifiers
ISSN
1546-0096
E-ISSN
1546-0096
DOI
10.1186/s12969-021-00526-0
